Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

201656 citationsJournal Articlegold Open Access

Authors

Carolin Cornelius · Medical University of Vienna

Katrin Schöneweis · Heidelberg University

Fanny Georgi · University Hospital Heidelberg

Milena Weber · Medical University of Vienna

Verena Niederberger · Medical University of Vienna

Petra Zieglmayer · Vienna Challenge Chamber

Katarzyna Niespodziana

Abstract

Our study demonstrates that the recombinant hypoallergenic grass pollen allergy vaccine BM32 induces hepatitis B-specific immune responses which protect against hepatitis B virus infection in vitro.

Topics & Keywords

Allergic Rhinitis and Sensitization Food Allergy and Anaphylaxis Research Dermatology and Skin Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: EBioMedicine

Volume 11, pp. 58-67

DOI: 10.1016/j.ebiom.2016.07.023

Field-Weighted Citation Impact: 6.41